Condition: IgA Nephropathy Severity in Kidney Transplantation · Sponsor: University Hospital, Strasbourg, France
ICONE study (IgA Complement and NEphropathy is a prospective monocentric observational study. The main objective is to evaluate the relevance of complement activation as a biomarker of disease severity and progression in patients with a biopsy proven IgAN.
This description comes directly from the study's public registry record.
Sophie Ohlmann- Caillard, MD · 03.88.11.67.68 · sophie.ohlmann@chru-strasbourg.fr
Always discuss trial participation with your own doctor first.
| Service de néphrologie | Strasbourg, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05234463